Literature DB >> 16165921

Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.

Magnus Essand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16165921     DOI： 10.1080/02841860510007477

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

Review 1.  Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.

Authors:  Victoria Hillerdal; Magnus Essand
Journal:  BioDrugs       Date:  2015-04       Impact factor: 5.807

2.  Evidence-based approaches to reduce cancer health disparities: Discover, develop, deliver, and disseminate.

Authors:  Priyanka P Desai; Jana B Lampe; Sulaimon A Bakre; Riyaz M Basha; Harlan P Jones; Jamboor K Vishwanatha
Journal:  J Carcinog       Date:  2018-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.